Prognostic Factor Analysis for Risk‐Stratified Papillary Thyroid Carcinoma and Nomogram Development for Predicting Structural Incomplete Response to Radioactive Iodine Therapy in Intermediate‐Risk Patients
Cancer Reports · 2026
DOI: 10.1002/cnr2.70692 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Reports, 2026. Verfasst von Yamin Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, The First Affiliated Hospital of Soochow University, Suzhou, China. Hauptthemen laut MEDLINE: Nomograms, Iodine Radioisotopes, Thyroid Neoplasms, Thyroid Cancer, Papillary. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Structural incomplete response (SIR) after radioactive iodine (RAI) therapy indicates persistent or recurrent structural disease and has important implications for the long‐term management of patients with papillary thyroid carcinoma (PTC). However, predictors of SIR across recurrence‐risk strata remain incompletely characterized.
Aims
To identify factors associated with SIR following RAI therapy in risk‐stratified PTC patients and to develop a predictive nomogram for intermediate‐risk patients. Methods and Results We retrospectively analyzed 615 PTC patients who underwent thyroidectomy, lymph‐node dissection, and 131 I therapy. Patients were re‐stratified according to the 2025 American Thyroid Association recurrence‐risk framework into a low/low‐to‐intermediate‐risk group and an intermediate‐high/high‐risk group. In 396 intermediate‐risk patients with lymph‐node metastasis, univariable and multivariable logistic regression analyses were used to identify independent predictors of SIR, and a nomogram was developed and internally validated. SIR rates differed significantly between risk groups ( p < 0.001). Stimulated thyroglobulin (sTg) independently predicted SIR across all risk strata. The number of lymph‐node metastases (LNM) and lymph‐node yield additionally predicted SIR in intermediate‐high/high‐risk patients. In intermediate‐risk patients, age, tumor size, lymph‐node ratio, sTg, and LNM were independent predictors of SIR. The nomogram yielded an area under the curve of 0.865 (95% CI, 0.814–0.916) in the training cohort and 0.733 (95% CI, 0.617–0.849) in the internal hold‐out validation cohort; the bootstrap optimism‐corrected area under the curve was 0.853, and the optimism‐corrected calibration slope was 0.92. Conclusion sTg and LNM are key predictors of SIR in risk‐stratified PTC patients. In this single‐center retrospective cohort, the nomogram showed good discrimination and calibration for SIR in intermediate‐risk patients; external multicenter validation is warranted before clinical application.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, The First Affiliated Hospital of Soochow University, Suzhou, China.
Zitieren
APA
Li, Y., He, Z., Zhao, M., & Zhang, B. (2026). Prognostic Factor Analysis for Risk‐Stratified Papillary Thyroid Carcinoma and Nomogram Development for Predicting Structural Incomplete Response to Radioactive Iodine Therapy in Intermediate‐Risk Patients. Cancer Reports. https://doi.org/10.1002/cnr2.70692
Vancouver
Li Y, He Z, Zhao M, Zhang B. Prognostic Factor Analysis for Risk‐Stratified Papillary Thyroid Carcinoma and Nomogram Development for Predicting Structural Incomplete Response to Radioactive Iodine Therapy in Intermediate‐Risk Patients. Cancer Reports. 2026. doi:10.1002/cnr2.70692
BibTeX
@article{Li2026,
author = {Li, Yamin and He, Zhaohui and Zhao, Min and Zhang, Bin},
title = {Prognostic Factor Analysis for Risk‐Stratified Papillary Thyroid Carcinoma and Nomogram Development for Predicting Structural Incomplete Response to Radioactive Iodine Therapy in Intermediate‐Risk Patients},
journal = {Cancer Reports},
year = {2026},
doi = {10.1002/cnr2.70692}
}
EUVIMED